Wilbe Capital LLP
wilbe.com Direct investor
Wilbe Capital is the investment arm of Wilbe Group, providing first checks to scientist founders who emerge from its Build Week cohorts. It also manages funds, including a first fund from 2022 and a second fund from 2025.
Wilbe Capital LLP is a venture capital firm, founded in 2020. It invests directly in companies, from pre-seed to seed, in AI & Computing, biotech and Multi-sector. Its stated cheque size is $100K-$700K.
“First checks of $100K-$700K for the top 1% of scientist founders, straight out of Build Week.”
— Wilbe Capital LLP, own website
- Layer
- Direct investor
- Type
- Venture capital
- Invests in
- global
- Sectors
- AI & Computing, Biotech, Multi-sector
- Cheque size
- $100K-$700K
- Founded
- 2020
Team, as Wilbe Capital LLP publishes it
- Ale Maiano CEO at Wilbe Group
- Devika Thapar COO at Wilbe Group
- Fabrizio Nicola-Giordano CEO at Wilbe Labs
- Jesse Zondervan, PhD Head of Venture Systems & Operations at Wilbe
- Alex Söderman Finance Director at Wilbe
- Subaita Rahman Community at Wilbe Labs
- Alyssa Sorzano Front of House at Wilbe Labs
Names and roles exactly as listed on wilbe.com. Nothing else about these people is recorded.
Where this comes from
Every fact above was read from a page Wilbe Capital LLP publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://www.wilbe.com/homename, is_investor, layer, type, invests_in_geographies, stage_min, stage_max, sectors, cheque_size, thesis_quote, thesis_quote_page, description, status, confidence
- https://www.wilbe.com/aboutfounded, people
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 10843 · added 2026-09-29 · link last verified not yet · confidence high
Similar investors
- 1517 FundVenture capital · Pre-seed – Seed · United States
- 7G BioVenturesVenture capital
- AbingworthVenture capital · Seed – Series C+ · London, United Kingdom
- AbstractVenture capital · Seed – Series C+ · San Francisco, United States
- ACE VenturesVenture capital · Seed – Series B · Switzerland
- AdBio PartnersVenture capital · Seed – Series A · Paris, France